Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Appointed director
Quarterly results
Acq. announced

ANI PHARMACEUTICALS INC (ANIP) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/21/2011 BW BioSante Pharmaceuticals Signs Melanoma Vaccine License
06/07/2011 BW BioSante Pharmaceuticals, Inc. To Present at Jefferies Global Healthcare Conference
05/18/2011 BW BioSante Pharmaceuticals, Inc. To Present at Two Upcoming Investor Conferences
05/10/2011 BW BioSante Pharmaceuticals Reports First Quarter Financial Results and Recent Developments
04/27/2011 BW BioSante Pharmaceuticals, Inc. To Present at the Deutsche Bank Annual Health Care Conference
04/18/2011 BW BioSante Pharmaceuticals Announces Pancreatic and Prostate Cancer Vaccine License
04/13/2011 BW BioSante Pharmaceuticals Announces Teva New Drug Application for Bio-T-Gel™
04/11/2011 BW BioSante Pharmaceuticals, Inc. To Present at Future Leaders in the Biotech Industry Conference
03/30/2011 BW BioSante Pharmaceuticals Completes Enrollment in Both Pivotal LibiGel® Phase III Efficacy Trials
03/16/2011 BW BioSante Pharmaceuticals Reports Financial Results for 2010 and Clinical Development and Business Highlights
03/09/2011 BW BioSante Pharmaceuticals Closes $25.1 Million Registered Direct Offering
03/04/2011 BW BioSante Pharmaceuticals to Raise $25.1 Million in Registered Direct Offering
03/03/2011 BW BioSante's Pancreas Cancer Vaccine Shows Survival Increase in Newly Published Study
02/24/2011 BW BioSante Pharmaceuticals Completes Enrollment in LibiGel® Phase III Efficacy Trial
02/22/2011 BW BioSante Pharmaceuticals, Inc. to Present at Citi Global Health Care Conference
02/15/2011 BW BioSante Presents Data Showing Female Sexual Dysfunction is a Significant Unmet Medical Need
02/14/2011 BW BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data in Phase III Program
02/14/2011 BW BioSante Pharmaceuticals, Inc. To Present LibiGel® Safety Study Update at BIO CEO & Investor Conference
02/12/2011 BW BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data in Phase III Program
11/17/2010 BW BioSante Pharmaceuticals Sells Oncolytic Virus Technology to Cold Genesys, Inc.
11/12/2010 BW BioSante Pharmaceuticals Reports Third Quarter 2010 Financial Results
10/26/2010 BW BioSante Pharmaceuticals, Inc. To Present at Two Upcoming Investor Conferences
10/25/2010 BW BioSante Pharmaceuticals Reports Positive LibiGel® Data Monitoring Committee Recommendation
10/18/2010 BW BioSante Pharmaceuticals Reaches Key LibiGel® Safety Study Enrollment Target
10/14/2010 BW BioSante Pharmaceuticals, Inc. To Present at Cancer Immunotherapy Conference
10/11/2010 BW BioSante Pharmaceuticals, Inc. Presents LibiGel® Clinical Study Update at North American Menopause Society Meeting
10/04/2010 BW BioSante Pharmaceuticals, Inc. To Present LibiGel® Clinical Trial Update at North American Menopause Society Meeting
09/30/2010 BW BioSante Pharmaceuticals to Present at the Bio Investor Forum
09/22/2010 BW BioSante Pharmaceuticals, Inc. To Present at the JMP Healthcare Conference
08/12/2010 BW BioSante Pharmaceuticals Reports Second Quarter 2010 Financial Results
07/13/2010 BW BioSante Pharmaceuticals Announces Initiation of LibiGel® Study to Evaluate its Effect on Cognitive Function in Women
06/30/2010 BW BioSante Pharmaceuticals Announces Positive Clinical Results in Pill-Plus™ Oral Contraceptive Study
06/23/2010 BW BioSante Pharmaceuticals Closes $15 Million Registered Direct Offering to Fund LibiGel® for Female Sexual Dysfunction
06/21/2010 BW BioSante Pharmaceuticals to Raise $15 Million in Registered Direct Offering
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy